Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|October 29, 2020
Extracellular DNA-A Danger Signal Triggering ImmunothrombosisChongxu Shi, Luying Yang, Attila Braun, et al.Kidney Diseases (Basel, Switzerland)|July 13, 2018
Novel Insights into Crystal-Induced Kidney InjuryShrikant R Mulay, Chongxu Shi, Xiaoyuan Ma, et al.Archives of Microbiology|February 11, 2015
PRRSV receptors and their roles in virus infectionChongxu Shi, Yali Liu, Yaozhong Ding, et al.The FEBS Journal|December 13, 2019
A guide to crystal-related and nano- or microparticle-related tissue responsesShrikant R Mulay, Stefanie Steiger, Chongxu Shi, et al.Atherosclerosis Plus|July 8, 2024
NAD+ metabolism and therapeutic strategies in cardiovascular diseasesChongxu Shi, Zhaozhi Wen, Yihang Yang, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 7, 2023
Pathophysiology and targeted treatment of cholesterol crystal embolism and the related thrombotic angiopathyChongxu Shi, Elmina Mammadova-Bach, Cong Li, et al.Frontiers in Immunology|February 20, 2026
NMN protects cisplatin-associated AKI via NAD+/SIRT1 pathwayZhaozhi Wen, Jiazeng Wang, Yihang Yang, et al.Kidney International|March 31, 2023
Both hyperglycemia and hyperuricemia aggravate acute kidney injury during cholesterol embolism syndrome despite opposite effects on kidney infarct sizeLuying Yang, Stefanie Steiger, Chongxu Shi, et al.Science Translational Medicine|May 27, 2026
CCR5 and CD74 are potential therapeutic targets for necroinflammation in preclinical cholesterol crystal embolismChongxu Shi, Zhaozhi Wen, Koulong Zheng, et al.Physiological Reports|August 30, 2018
IL-22 sustains epithelial integrity in progressive kidney remodeling and fibrosisMarc Weidenbusch, Shangqing Song, Takamasa Iwakura, et al.Pageof 2